Balaji Amines Limited has reported robust growth for the quarter and year ended March 31, 2026. The company achieved a consolidated annual profit of Rs 16,915.68 lakhs, reflecting strong operational performance across its business segments. Furthermore, the Board has recommended a final dividend of Rs 11 per equity share (550% of the face value), subject to shareholder approval at the upcoming Annual General Meeting.
Annual Financial Performance Highlights
For the financial year ended March 31, 2026, Balaji Amines delivered solid growth. The company reported a total consolidated income of Rs 1,45,378.74 lakhs for the year. Net profit attributable to shareholders reached Rs 16,719.99 lakhs, underscoring the company’s ability to maintain healthy margins despite evolving market conditions. The standalone net profit for the same period was recorded at Rs 16,552.83 lakhs.
Quarterly Growth Analysis
The company’s performance in the final quarter (Q4) of the fiscal year showed a marked upward trend. The consolidated revenue from operations for the quarter ended March 31, 2026, stood at Rs 39,478.64 lakhs, compared to Rs 33,130.10 lakhs in the previous quarter. Consolidated profit for the period rose significantly to Rs 6,477.05 lakhs, demonstrating strong momentum in operational efficiency as the fiscal year concluded.
Segment-Wise Results
The Amines & Speciality Chemicals division remains the primary growth engine for the company, contributing Rs 1,41,568.99 lakhs to the annual segment revenue. The Hotel Division continued to provide stable contributions, reporting an annual revenue of Rs 3,570.15 lakhs. The company’s consolidated assets reached a total value of Rs 2,74,253.69 lakhs, providing a firm foundation for future operations and capacity expansion.
Dividend and Strategic Outlook
Reflecting the company’s commitment to delivering value to its stakeholders, the Board of Directors has recommended a final dividend of Rs 11 per equity share, representing a 550% return on the face value of Rs 2 per share. This payout remains subject to the final approval of shareholders during the 38th Annual General Meeting.
Source: BSE
